Public EUDAMED Search

EUDAMED Device Search

A readable public search layer for EUDAMED device, manufacturer, UDI, EMDN and risk class data.

TR EN

Last updated

23.09.2026 17:11

Sync status

Successful

Device

3578159

Actor

47824

Certificate

3401

Filters

Show filters

Active filter:Manufacturer SRN:DE-MF-000007407

306 device results listed.

Page 4 / 16

CSV XML

Aspecton Nasenspray

Class IIaNot specifiedOn the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778107996
Basic UDI-DI: 42517781MD343CX
Reference: MD343
EMDN: Q030199
EMDN description: NASOPHARYNGEAL DEVICES - OTHER
First on market country: Germany
Authorised representative: -
Last updated: 31.07.2026 01:07

Manufacturer products View details

Pump Dosing System

Pump Dosing System 0.5ml

Class IMDR 2017/745On the market

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778103011
Basic UDI-DI: 42517781MD236CV
Reference: 31087379
EMDN: A99
EMDN description: DEVICES FOR ADMINISTRATION, WITHDRAWAL AND COLLECTION - OTHER
First on market country: Germany
Authorised representative: -
Last updated: 31.07.2026 01:07

Manufacturer products View details

Detall

Class IIaMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778101710
Basic UDI-DI: 42517781MD229CY
Reference: 100001
EMDN: A13
EMDN description: APPLICATORS FOR DRUGS AND MEDICAL DEVICES NOT PRESENT IN OTHER CLASSES
First on market country: Germany
Authorised representative: -
Last updated: 31.07.2026 01:07

Manufacturer products View details

Granulox

Class IIIMDR 2017/745On the marketAnimal tissues

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778107873
Basic UDI-DI: 42517781MD910DE
Reference: 360001
EMDN: V9099
EMDN description: VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER
First on market country: Germany
Safety summary (SSCP/SSP): SSCP_MÖLN_Granu_MD910 · Rev. 2
Authorised representative: -
Last updated: 30.07.2026 02:38

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106234
Basic UDI-DI: 42517781MD339D8
Reference: 1571308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: Germany
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:38

Manufacturer products Open in EUDAMED View details

3558GB414200519

Eucerin Actinic Control MD SPF 100

Class IIaMDDOn the market

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: D-MD136TZ
Basic UDI-DI: B-MD136TZ
Reference: 83585-00000-01
EMDN: V9099
EMDN description: VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER
First on market country: Italy
Authorised representative: -
Last updated: 30.07.2026 02:33

Manufacturer products View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106241
Basic UDI-DI: 42517781MD339D8
Reference: 1571391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106258
Basic UDI-DI: 42517781MD339D8
Reference: 1571373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106265
Basic UDI-DI: 42517781MD339D8
Reference: 572308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106272
Basic UDI-DI: 42517781MD339D8
Reference: 572391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106289
Basic UDI-DI: 42517781MD339D8
Reference: 572373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106296
Basic UDI-DI: 42517781MD339D8
Reference: 573308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106302
Basic UDI-DI: 42517781MD339D8
Reference: 573391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106319
Basic UDI-DI: 42517781MD339D8
Reference: 573373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106326
Basic UDI-DI: 42517781MD339D8
Reference: 574308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106333
Basic UDI-DI: 42517781MD339D8
Reference: 574391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106340
Basic UDI-DI: 42517781MD339D8
Reference: 574373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106357
Basic UDI-DI: 42517781MD339D8
Reference: 314571308
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106364
Basic UDI-DI: 42517781MD339D8
Reference: 314571391
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details

Refluthin

Class IIIMDR 2017/745On the marketSingle use

Manufacturer: HÄLSA Pharma GmbH
Manufacturer SRN: DE-MF-000007407
UDI-DI: 04251778106371
Basic UDI-DI: 42517781MD339D8
Reference: 314571373
EMDN: G0401
EMDN description: ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country: -
Safety summary (SSCP/SSP): SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative: -
Last updated: 30.07.2026 02:29

Manufacturer products Open in EUDAMED View details